Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Clinical trial NCT03790488 · COMPLETED
Trial details
- NCT number
- NCT03790488
- Sponsor
- Jounce Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2019-07-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.